Ran Poliakine

Nanox to Present at the Ladenburg Thalmann Healthcare Conference

Retrieved on: 
Thursday, July 1, 2021
Ran Poliakine, Medical physics, Medical imaging, Design, Applied sciences, Academic disciplines

Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.

Key Points: 
  • Mr. Poliakines presentation is scheduled for Wednesday, July 14, at 10:00am ET.
  • Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision .
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Nanox Announces FDA 510(k) Submission for First Version of Multi-Source Nanox.ARC

Retrieved on: 
Thursday, June 17, 2021
Ran Poliakine, Tomosynthesis, Food and Drug Administration, Medical imaging, Medicine, Health

The 510(k) submission for the first version of our multi-source Nanox.ARC is an important achievement, stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.

Key Points: 
  • The 510(k) submission for the first version of our multi-source Nanox.ARC is an important achievement, stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.
  • There exists a significant unmet medical need globally for a more accessible and cost-effective medical imaging solution.
  • If cleared by the FDA, we believe our Nanox.ARC 3-D digital tomosynthesis can address this need.
  • Nanox received FDA clearance of its single source Nanox Cart X-Ray System in April 2021.

Update – Nanox to Participate in the Jefferies Virtual Healthcare Conference

Retrieved on: 
Thursday, May 27, 2021
Ran Poliakine, Webcast, Telecommunications, Mass media, Service industries

Mr. Poliakines presentation is scheduled for Friday, June 4, at 10:00am ET.

Key Points: 
  • Mr. Poliakines presentation is scheduled for Friday, June 4, at 10:00am ET.
  • The presentation will be accessible via a live webcast at: https://wsw.com/webcast/jeff174/nani/1840266
    Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision .
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Nanox to Participate in the Jefferies Virtual Healthcare Conference

Retrieved on: 
Wednesday, May 26, 2021
Ran Poliakine, Design, Occupations

NEVE ILAN, Israel, May 26, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, today announces that Nanoxs Chairman and Chief Executive Officer Ran Poliakine will make a company presentation and the leadership team will host investor 1x1 meetings during the Jefferies Virtual Healthcare Conference, which is being held June 1st through June 4th.

Key Points: 
  • NEVE ILAN, Israel, May 26, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, today announces that Nanoxs Chairman and Chief Executive Officer Ran Poliakine will make a company presentation and the leadership team will host investor 1x1 meetings during the Jefferies Virtual Healthcare Conference, which is being held June 1st through June 4th.
  • Mr. Poliakines presentation is scheduled for Thursday, June 3, at 4:30pm ET.
  • The presentation will be accessible via a live webcast at: https://wsw.com/webcast/jeff174/nani/1840266
    Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision .
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

Retrieved on: 
Monday, May 3, 2021
Ran Poliakine, NASDAQ, Finance, Design

b"NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ: NNOX) (\xe2\x80\x9cNanox\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021.

Key Points: 
  • b"NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ: NNOX) (\xe2\x80\x9cNanox\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021.
  • Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products.\n\xe2\x80\x9cMoshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field,\xe2\x80\x9d stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.
  • Prior to that, he served as Head of Global Sales and Marketing at Truphatek International Ltd., a leading global medical device company.
  • Before that, Mr. Shtengel was Head of Clinical Trial and Compliance Business Unit at BJC Healthcare, one of the largest health care organizations in the United States.\nMr.

NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

Retrieved on: 
Tuesday, April 6, 2021
Financial statements, Ran Poliakine, Medical imaging, Design, Occupations

NEVE ILAN, Israel, April 06, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (Nanox or the Company), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC) on April 6, 2021.

Key Points: 
  • NEVE ILAN, Israel, April 06, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (Nanox or the Company), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC) on April 6, 2021.
  • The annual report on Form 20-F, which contains the Companys audited consolidated financial statements, can be accessed on the SECs website at www.sec.gov and on the Companys website at www.nanox.vision under Financials in the Investors section.
  • The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request.
  • Nano-X, founded by the serial entrepreneur Ran Poliakine is an Israeli corporation developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.

Nanox Announces FDA Clearance of 510(k) for Single Source Nanox.ARC Digital X-Ray

Retrieved on: 
Friday, April 2, 2021
Medical physics, Radiation, Ran Poliakine, Electromagnetic radiation, Nuclear medicine, Food and Drug Administration, X-ray, Medical imaging, Medicine

Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway, stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.

Key Points: 
  • Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway, stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.
  • The Company remains on track and expects to submit a 510(k) application to the FDA for its multi-source Nanox.ARC and the Nanox.CLOUD in 2021.
  • If cleared, the multi-source Nanox.ARC will be the Companys commercial imaging system that it expects to deploy broadly across the globe.
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.

Nanox Announces FDA Clearance of 510(k) for Single Source Nanox.ARC Digital X-Ray

Retrieved on: 
Friday, April 2, 2021
Health, FDA, Medical devices, Technology, Other Technology, Software, Radiology, Medical physics, Radiation, Ran Poliakine, Electromagnetic radiation, Medical imaging, Food and Drug Administration, X-ray, Medicine, Draft:Nanox imaging

NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announced today that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration (the FDA).

Key Points: 
  • NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announced today that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration (the FDA).
  • Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway, stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox.
  • The Company remains on track and expects to submit a 510(k) application to the FDA for its multi-source Nanox.ARC and the Nanox.CLOUD in 2021.
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.

Nanox to Participate in the Virtual 31st Annual Oppenheimer Healthcare Conference

Retrieved on: 
Monday, March 15, 2021
Ran Poliakine, Webcast, Telecommunications, Mass media, Service industries

NEVE ILAN, Israel, March 15, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, today announces that Nanoxs Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Oppenheimer 31st Annual Virtual Healthcare Conference, which is being held from March 16 through March 18.

Key Points: 
  • NEVE ILAN, Israel, March 15, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, today announces that Nanoxs Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Oppenheimer 31st Annual Virtual Healthcare Conference, which is being held from March 16 through March 18.
  • Mr. Poliakines presentation is scheduled for Wednesday, March 17, at 10:40am ET.
  • The presentation will be accessible via a live webcast at: https://wsw.com/webcast/oppenheimer9/nani/2701886
    Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the company's website at www.nanox.vision .
  • The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.

Nanox to Participate in the Virtual 39th Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 11, 2021
Ran Poliakine, Webcast, Telecommunications, Mass media, Service industries

Mr. Poliakine s presentation is scheduled for Thursday, January 14, at 9:10am ET.

Key Points: 
  • Mr. Poliakine s presentation is scheduled for Thursday, January 14, at 9:10am ET.
  • The presentation will be accessible via a live webcast at: https://jpmorgan.metameetings.net/events/healthcare21/sessions/36567-nan...
    Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the company's website at www.nanox.vision .
  • The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.
  • Nano-X, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.